Pain is a key symptom in hidradenitis suppurativa (HS) and up to one-third of patients use cannabis. Despite this clinical signal, the endocannabinoid system (ECS) and molecular nociceptive networks remain essentially uncharacterized. Transcriptomic comparisons between HS patients and healthy controls were conducted utilizing bulk RNA-seq (blood and skin) alongside cutaneous scRNA-seq. A curated 134-gene panel mapped the peripheral nociceptive network, encompassing neurotrophic and immune signaling, extracellular matrix remodeling, and bioactive lipid mediators. Compared with healthy controls, bulk transcriptomic profiling of HS patients revealed nine ECS-related genes differentially expressed in lesional skin and eight in the blood. Additionally, seven distinct bioactive lipid mediator genes were dysregulated within HS lesions, suggesting a lesion-level shift in prostaglandin, thromboxane, and leukotriene biosynthesis. At single-cell resolution, of the five major cell populations analyzed, keratinocytes and T cells played a relatively minor role in the broader pain signature. In contrast, mononuclear phagocytes (MNPs) and fibroblasts emerged as central cellular amplifiers of peripheral nociception. MNPs significantly dysregulated 48 panel genes, including the biosynthetic machinery for nociceptive lipid mediators across the endocannabinoid, prostaglandin, leukotriene, and thromboxane axes. Moreover, MNPs amplify pain networks by inducing pronociceptive chemokines, cytokines, alarmins, neuropeptides, mechanotransducers, and matrix-remodeling proteases, a shift potentiated by substantial hypoxic and oxidative adaptations. Fibroblasts exhibited a broad transcriptomic shift altering 46 pain-network genes, dysregulating matrix-remodeling, inflammatory, and lipid mediator pathways. Critically, the alteration of neurotrophic factors, plasminogen activators, and axon guidance molecules suggest a permissive environment for disorganized hyperinnervation. Furthermore, the sensory ion channel TRPA1 emerged as a significantly upregulated stromal sensor, with this entire nociceptive signature correlating with CXCL13-positive immunofibroblasts. Additionally, leveraging the high B cell density in HS lesions enabled a novel intratissue trajectory analysis, revealing constitutive lipid mediator expression without significant transcriptomic shifts across memory, plasmablast, and plasma cell maturation stages. Finally, in silico intersection of this pathogenic profile with the druggable proteome identified precision therapeutic candidates, encompassing targetable GPCRs, FDA-approved monoclonal antibodies against inflammatory nodes, and experimental sphingolipid and leukotriene cascade inhibitors. Collectively, this study establishes the first systematic transcriptomic map of the peripheral nociceptive network and endocannabinoidome in hidradenitis suppurativa, providing both a mechanistic framework for disease-associated nociception and a biological rationale for targeted therapeutic intervention.